275 related articles for article (PubMed ID: 21410721)
1. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
[TBL] [Abstract][Full Text] [Related]
2. Psychological impact of surveillance in patients with a defibrillator lead under advisory: a prospective evaluation.
D'Antono B; Goldfarb M; Solomon C; Sturmer M; Becker G; Essebag V; Hadjis T; Gizicki E; Gelais JS; Sas G; Côté MC; Kus T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):221-30. PubMed ID: 23121081
[TBL] [Abstract][Full Text] [Related]
3. Psychological adjustment in ICD patients living with advisory fidelis leads.
Keren A; Sears SF; Nery P; Shaw J; Green MS; Lemery R; Gollob MH; Amyotte B; Birnie DH
J Cardiovasc Electrophysiol; 2011 Jan; 22(1):57-63. PubMed ID: 20731739
[TBL] [Abstract][Full Text] [Related]
4. Psychological distress in patients with ICD recall.
Cuculi F; Herzig W; Kobza R; Erne P
Pacing Clin Electrophysiol; 2006 Nov; 29(11):1261-5. PubMed ID: 17100681
[TBL] [Abstract][Full Text] [Related]
5. Update on small-diameter implantable cardioverter-defibrillator leads performance.
van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
[TBL] [Abstract][Full Text] [Related]
6. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification.
Pedersen SS; Versteeg H; Nielsen JC; Mortensen PT; Johansen JB
Europace; 2011 Sep; 13(9):1292-8. PubMed ID: 21616945
[TBL] [Abstract][Full Text] [Related]
8. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience.
Birnie DH; Sears SF; Green MS; Lemery R; Gollob MH; Amyotte B
Europace; 2009 Jan; 11(1):26-30. PubMed ID: 19010798
[TBL] [Abstract][Full Text] [Related]
9. Right-sided implantation and subpectoral position are predisposing factors for fracture of a 6.6 French ICD lead.
Bernstein NE; Karam ET; Aizer A; Wong BC; Holmes DS; Bernstein SA; Chinitz LA
Pacing Clin Electrophysiol; 2012 Jun; 35(6):659-64. PubMed ID: 22469148
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
11. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
[TBL] [Abstract][Full Text] [Related]
12. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead.
Ha AC; Vezi BZ; Keren A; Alanazi H; Gollob MH; Green MS; Lemery R; Nery PB; Posan E; Birnie DH
Pacing Clin Electrophysiol; 2010 Apr; 33(4):437-43. PubMed ID: 19954500
[TBL] [Abstract][Full Text] [Related]
13. Impact of implanted recalled sprint Fidelis lead on patient mortality.
Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
[TBL] [Abstract][Full Text] [Related]
15. The psychological impact of implantable cardioverter-defibrillator recalls and the durable positive effects of counseling.
Fisher JD; Koulogiannis KP; Lewallen L; Katz D; Kim SG; Ferrick KJ; Gross JN; Krumerman AK; Johnston DR; Mercaldi BC
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1012-6. PubMed ID: 19659621
[TBL] [Abstract][Full Text] [Related]
16. Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead.
Kenigsberg DN; Mirchandani S; Dover AN; Kowalski M; Wood MA; Shepard RK; Kalahasty G; Stein KM; Markowitz SM; Iwai S; Shah BK; Lerman BB; Mittal S; Ellenbogen KA
J Cardiovasc Electrophysiol; 2008 Mar; 19(3):270-4. PubMed ID: 18179527
[TBL] [Abstract][Full Text] [Related]
17. Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients.
Mahajan T; Dubin AM; Atkins DL; Bradley DJ; Shannon KM; Erickson CC; Franklin WH; Cecchin F; Berul CI;
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1270-4. PubMed ID: 18691353
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
[TBL] [Abstract][Full Text] [Related]
19. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
Pedersen SS; Theuns DA; Jordaens L; Kupper N
Europace; 2010 Aug; 12(8):1119-26. PubMed ID: 20507853
[TBL] [Abstract][Full Text] [Related]
20. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?
Amin MS; Ellenbogen KA
Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
